Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog

被引:17
作者
Ramos, Carolina de Oliveira [1 ]
Macedo, Delanie B. [1 ]
Canton, Ana Pinheiro M. [1 ]
Cunha-Silva, Marina [1 ]
Antonini, Sonir R. R. [2 ,3 ]
Stecchini, Monica Freire [2 ,3 ]
Seraphim, Carlos Eduardo [1 ]
Rodrigues, Tania [4 ]
Mendonca, Berenice Bilharinho [1 ]
Latronico, Ana Claudia [1 ]
Brito, Vinicius Nahime [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Disciplina Endocrinol & Metabol, Unidade Endocrinol Desenvolvimento, Sao Paulo, Brazil
[2] Hosp Clin Sao Paulo, Lab Hormonios & Genet Mol LIM 42, Sao Paulo, Brazil
[3] Univ Sao Paulo, Escola Med Ribeirao Preto, Dept Pediat, Ribeirao Preto, Brazil
[4] Univ Fed Juiz de Fora, Dept Med, Campus Governador Valadares, Governador Valadares, Brazil
关键词
Central precocious puberty; Gonadotropin-releasing hormone analog; MKRN3; Final height; Body composition; Gonadal function; BODY-MASS INDEX; LONG-TERM TREATMENT; FINAL HEIGHT; SUPPRESSIVE THERAPY; UNTREATED WOMEN; ADULT HEIGHT; GIRLS; DIAGNOSIS; PATTERN; HEALTH;
D O I
10.1159/000504446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction:Loss-of-function mutation ofMKRN3represents the most frequent genetic cause of familial central precocious puberty (CPP). The outcomes of gonadotropin-releasing hormone analog (GnRHa) treatment in CPP patients withMKRN3defects are unknown.Objective:To describe the clinical and hormonal features of patients with CPP with or withoutMKRN3mutations after GnRHa treatment. Anthropometric, metabolic and reproductive parameters were evaluated.Patients and Methods:Twenty-nine female patients with CPP due to loss-of-function mutations in theMKRN3and 43 female patients with idiopathic CPP were included. Their medical records were retrospectively evaluated for clinical, laboratory, and imaging study, before, during, and after GnRHa treatment. All patients with idiopathic CPP and 11 patients with CPP due toMKRN3defects reached final height (FH).Results:At the diagnosis, there were no significant differences between clinical and laboratory features of patients with CPP with or withoutMKRN3mutations. A high prevalence of overweight and obesity was observed in patients with CPP with or withoutMKRN3mutations (47.3 and 50%, respectively), followed by a significant reduction after GnRHa treatment. No significant differences in the values of mean FH and target height were found between the 2 CPP groups after GnRHa treatment. Menarche occurred at the expected age in patients with or without CPP due toMKRN3mutations (11.5 +/- 1.3 and 12 +/- 0.6 years, respectively). The prevalence of polycystic ovarian syndrome was 9.1% in patients with CPP due toMKRN3mutations and 5.9% in those with idiopathic CPP.Conclusion:Anthropometric, metabolic, and reproductive outcomes after GnRHa treatment were comparable in CPP patients, with or withoutMKRN3mutations, suggesting the absence of deleterious effects ofMKRN3defects in young female adults' life.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 35 条
[1]   Central Precocious Puberty Caused by Mutations in the Imprinted Gene MKRN3 [J].
Abreu, Ana Paula ;
Dauber, Andrew ;
Macedo, Delanie B. ;
Noel, Sekoni D. ;
Brito, Vinicius N. ;
Gill, John C. ;
Cukier, Priscilla ;
Thompson, Iain R. ;
Navarro, Victor M. ;
Gagliardi, Priscila C. ;
Rodrigues, Tania ;
Kochi, Cristiane ;
Longui, Carlos Alberto ;
Beckers, Dominique ;
de Zegher, Francis ;
Montenegro, Luciana R. ;
Mendonca, Berenice B. ;
Carroll, Rona S. ;
Hirschhorn, Joel N. ;
Latronico, Ana Claudia ;
Kaiser, Ursula B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (26) :2467-2475
[2]   Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty [J].
Arrigo, T ;
De Luca, F ;
Antoniazzi, F ;
Galluzzi, F ;
Segni, M ;
Rosano, M ;
Messina, MF ;
Lombardo, F .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (04) :533-537
[3]   High Frequency of MKRN3 Mutations in Male Central Precocious Puberty Previously Classified as Idiopathic [J].
Bessa, Danielle S. ;
Macedo, Delanie B. ;
Brito, Vinicius N. ;
Franca, Monica M. ;
Montenegro, Luciana R. ;
Cunha-Silva, Marina ;
Silveira, Leticia G. ;
Hummel, Tiago ;
Bergada, Ignacio ;
Braslavsky, Debora ;
Abreu, Ana Paula ;
Dauber, Andrew ;
Mendonca, Berenice B. ;
Kaiser, Ursula B. ;
Latronico, Ana Claudia .
NEUROENDOCRINOLOGY, 2017, 105 (01) :17-25
[4]   Evidence for multiple determinants of the body mass index: The National Heart, Lung, and Blood Institute Family Heart Study [J].
Borecki, IB ;
Higgins, M ;
Schreiner, PJ ;
Arnett, DK ;
Meyer-Davis, E ;
Hunt, SC ;
Province, MA .
OBESITY RESEARCH, 1998, 6 (02) :107-114
[5]   Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs [J].
Brito, Vinicius Nahime ;
Latronico, Ana Claudia ;
Cukier, Priscilla ;
Teles, Milena Gurgel ;
Silveira, Leticia F. G. ;
Prado Arnhold, Ivo Jorge ;
Mendonca, Berenice Bilharinho .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) :2662-2669
[6]   Diagnostic value of fluorometric assays in the evaluation of precocious puberty [J].
Brito, VN ;
Batista, MC ;
Borges, MF ;
Latronico, AC ;
Kohek, MBF ;
Thirone, ACP ;
Jorge, BH ;
Arnhold, IJP ;
Mendonca, BB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3539-3544
[7]   Precocious puberty [J].
Carel, Jean-Claude ;
Leger, Juliane .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (22) :2366-2377
[8]   Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children [J].
Carel, Jean-Claude ;
Eugster, Erica A. ;
Rogol, Alan ;
Ghizzoni, Lucia ;
Palmert, Mark R. .
PEDIATRICS, 2009, 123 (04) :E752-E762
[9]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[10]   Body Mass Index and Body Composition in Adolescents Treated with Gonadotropin-Releasing Hormone Analogue Triptorelin Depot for Central Precocious Puberty: Data at Near Final Height [J].
Chiocca, Elena ;
Dati, Eleonora ;
Baroncelli, Giampiero I. ;
Mora, Stefano ;
Parrini, Donatella ;
Erba, Paola ;
Bertelloni, Silvano .
NEUROENDOCRINOLOGY, 2009, 89 (04) :441-447